India's Anlon Healthcare jumps on new anti-malarial products
** Shares of Anlon Healthcare ANLN.NS rise 6.3% to 142.99 rupees ** Pharma co says it has developed two new anti-malarial products, Artemether and Lumefantrine ** Both to be launched in November ** Stock set to gain for fifth straight session ** ANLN up nearly 55% from trading debut open price September 3 (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Anlon Healthcare
See all newsBrief: Anlon Healthcare Approves Issue Of Bonus Shares In The Ratio Of 1:1
Brief: Anlon Healthcare Ltd Says Appointment Of Naimish Dilipbhai Bhatt As CFO
Brief: Anlon Healthcare Approves New Product Development Programme
Brief: Anlon Healthcare Signs SPA To Buy Stake In Bizotic Lifescience Worth 38 Million Rupees
Brief: Anlon Healthcare To Buy 56.67% Stake In Bizotic Lifescience For 38 Million Rupees